https://pbs.twimg.com/media/FheRZk_WYAIWXYW.jpg
Spangler et al. No increased risk of MI or stroke in denosumab vs zoledronate in 170,000 patients from Optum/MarketScan. @RheumNow #ACR22 Abstr#0575 https://t.co/5fho4WBsIG https://t.co/PNCI4xJ38u

Links:

Myocardial Infarction and Stroke Risks Among Patients Who Initiated Treatment w… https://acrabstracts.org/abstract/myocardial-infarction-and-stroke-risks-among-…
Richard Conway
RichardPAConway
13-11-2022
How well do you know this week's rheumatology news?
Take the rheumIQ quiz
Take the RheumIQ Quiz

×